ANXA5 and head and neck carcinoma: Clinical studies utilizing annexin V probes have been limited; 99mTc-HYNIC-annexin-V, was tested in early clinical trials but its performance in detecting apoptosis in head and neck carcinoma was limited by moderate non-specific binding and slow clearance times (77).